Gilead Sciences, Inc. (GILD)
SIX
120.18
-0.84 (-0.69%)
Real-time Data
07:00 AM
Day's Range
120.18120.18
52 wk Range
98.58125.06
Financial Statements - GILD - Gilead Sciences, Inc.
Revenue
29.44B
Net Income
8.51BNet Margin 28.9%
EBITDA
14.80B
Free Cash Flow
9.45B
Income Statement
| Period Ending | 2025-12-31 |
|---|---|
| Sales | 29.44B |
| Cost of Goods | 6.23B |
| Gross Profit | 23.20B |
 Operating Expense | - |
| Operating Income | 11.70B |
| Non-Operating Interest | - |
| Other Income Expense | -1.23B |
| Pre Tax Income | 9.79B |
| Income Tax | 1.28B |
| Net Income | 8.51B |
| EPS Basic | 6.84 |
| EPS Diluted | 6.78 |
| Basic Shares Outstanding | 1.24B |
| Diluted Shares Outstanding | 1.24B |
| Ebit | 10.82B |
| Ebitda | 14.80B |
| Net Income Continuous Operations | 8.51B |
| Minority Interests | 0 |
| Preferred Stock Dividends | - |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
